Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-26-007004
Filing Date
2026-08-06
Accepted
2026-08-06 11:26:56
Documents
1
Period of Report
2026-08-05

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 3033
  Complete submission text file 0001225208-26-007004.txt   4540
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Issuer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PFIZER INC. CORPORATE SECRETARY 66 HUDSON BOULEVARD EAST NEW YORK NY 10001
Business Address
DAMICO JENNIFER B. (Reporting) CIK: 0001805617 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-03619 | Film No.: 261247568